​

Funding Round

Series A - Azafaros

Series A - Azafaros

Investment Firm

Overview

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

Announced Date

Feb 06, 2020

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners is a early_stage_venture and post_ipo and seed firm.

Participant Investors

3

Investor Name
Participant InvestorBioMedPartners
Participant InvestorForbion Capital Partners
Participant InvestorBioGeneration Ventures

Round Details and Background

Azafaros raised $27453009 on 2020-02-06 in Series A

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 23, 2018
Seed Round - Azafaros
1-undefined
Feb 06, 2020
Series A - Azafaros
3-27.5M

Recent Activity

There is no recent news or activity for this profile.